Status:
COMPLETED
Fiducial Localization and Individualized Radiotherapy -Prostate Cancer
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This purpose of this study is designed to compare two types of images; magnetic resonance imaging (MRI) and Trans-Rectal Ultrasound (TRUS) to see which one performs more accurately for the image-guide...
Detailed Description
The success of dose escalation strategies in prostate cancer over the last decade has relied on high accuracy in target delineation, localization and radiation delivery. Improved biochemical control w...
Eligibility Criteria
Inclusion
- ≥ 18 years old
- ECOG status ≤ 1
- High risk localized cancer planned for RT under FM guidance
- Gleason \> 7, PSA \> 20, Clinical stage ≥ T3
- patients(pts) must give written informed consent
Exclusion
- pts \> 136 kg or \> 60 cm in girth
- Pts with pacemakers, cerebral aneurysm clips, shrapnel injury or devices not compatible with MRI.
- pts with severe claustrophobia
- pts with bleeding diathesis and anticoagulative therapy that cannot be ceased prior to needle procedures.
- Contraindications to endorectal probe, surgically absent rectum, severe hemorrhoids or previous colorectal surgery.
- Latex Allergy
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 12 2023
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00789607
Start Date
June 1 2008
End Date
May 12 2023
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2M9